June 27, 2020
Research with Human Subjects
Research activities at The Neuro with patient populations and healthy subjects are scheduled to resume on July 6, 2020.
Note the following individuals will be excluded from participating in studies:
- those with immune-compromised conditions
- those with COVID-19 symptoms
- those aged 70 and older
This plan follows the directives received from Mr. Pierre Lafleur, sous-ministre adjoint, MSSS and recommendations from the MUHC Research Ethics Board (REB) and Dr. Ewa Rajda, Infectious Diseases, Infection Prevention and Control, Division of Medical Microbiology, MUHC.
Health and safety are our top priority
All Neuro staff and trainees need to have the same information and share the same recommendations.
The restart of research activities at The Neuro follows the McGill University on-campus research phase-in directives and the guidelines on preventing spread of COVID-19.
Neuro Principal Investigators are expected to be familiar with, and abide by all university directives and guidelines to plan a safe and gradual return to work.
As part of the process to resume research activities involving human subjects, all staff must be aware of the current guidelines and protocols
*Important: Please be sure to include specific SOPs and details regarding COVID-19 symptom screening of subjects prior to study, how subjects will access The Neuro and be guided to study area, health and safety precautions etc.
For more information contact: communications.neuro [at] mcgill.ca (Neuro Communications)